Der Kaninchen Polyklonal anti-MAPK14 Antikörper wird verwendet zum Nachweis von MAPK14 in Proben von Human, Maus und Ratte. Er wurde validiert für WB, IP und IHC (p).
Western blotting (0.5-4.0 μg/mL). Immunoprecipitation (10-20 μg/mL). Immunohistochemistry (10-20 μg/mL). Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
This product contains thimerosal (merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung
Avoid repeated freezing and thawing.
Lagerung
-20 °C
Informationen zur Lagerung
Store undiluted (in aliquots) at -20 °C to -70 °C.
Target
MAPK14
(Mitogen-Activated Protein Kinase 14 (MAPK14))
Andere Bezeichnung
MAP Kinase p38 alpha / MAPK14
Hintergrund
P38 MAP kinase is the mammalian homologue of the yeast HOG kinase and participates in a cascade controlling cell cellular responses to cytokines and stress. Like the SAPK/JNK pathway, p38 MAP kinase is activated by a variety of cellular stresses including inflammatory cytokines, UV light and growth factors, etc. Activated p38 MAP kinase has been shown to phosphorylate and activate MAPKAP kinase-2 and to phosphorylate the transcription factors ATF-2 and Max.Synonyms: CSBP, CSBP1, CSBP2, CSPB1, Cytokine suppressive anti-inflammatory drug-binding protein, MAX-interacting protein 2, MXI2, Mitogen-activated protein kinase 14, SAPK2A, p38 alpha